Creative Planning Vir Biotechnology, Inc. Transaction History

Creative Planning

  • $101 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$7.63 - $12.66 $41,087 - $68,174
5,385 Added 24.69%
27,198 $242,000
Q1 2024

May 10, 2024
BUY
$8.6 - $11.9 $40,050 - $55,418
4,657 Added 27.15%
21,813 $220,000
Q4 2023

Feb 14, 2024
BUY
$7.76 - $10.29 $133,130 - $176,535
17,156 New
17,156 $172,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $979M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email